Literature DB >> 20949359

Intervention in at-risk states for developing psychosis.

Stephan Ruhrmann1, Frauke Schultze-Lutter, Andreas Bechdolf, Joachim Klosterkötter.   

Abstract

Indicated prevention is currently one of the most promising approaches to fight the individual and societal burden associated with psychosis and particularly schizophrenia. The number of studies is still limited, yet encouraging results have been reported from pharmacological and psychotherapeutic trials. Furthermore, it has become clear that persons characterized by the at-risk criteria are already ill and do not only need preventive intervention but also treatment. As is indicated by a recent study successfully using omega-3 fatty acids for both purposes, it may be promising to develop and investigate interventions especially for the at-risk state, independent of their effectiveness in manifest disease states. An overview on the current findings and ongoing research in this area is provided.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20949359     DOI: 10.1007/s00406-010-0139-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  31 in total

1.  Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.

Authors:  Anthony P Morrison; Paul French; Sophie Parker; Morwenna Roberts; Helen Stevens; Richard P Bentall; Shôn W Lewis
Journal:  Schizophr Bull       Date:  2006-09-14       Impact factor: 9.306

Review 2.  Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions.

Authors:  Patrick D McGorry; Ian B Hickie; Alison R Yung; Christos Pantelis; Henry J Jackson
Journal:  Aust N Z J Psychiatry       Date:  2006-08       Impact factor: 5.744

3.  Axis-I disorders and vulnerability to psychosis.

Authors:  Tanja Svirskis; Jyrki Korkeila; Markus Heinimaa; Jukka Huttunen; Tuula Ilonen; Terja Ristkari; Thomas McGlashan; Raimo K R Salokangas
Journal:  Schizophr Res       Date:  2004-12-02       Impact factor: 4.939

4.  Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment.

Authors:  Andreas Bechdolf; Stephan Ruhrmann; Michael Wagner; Kai Uwe Kühn; Birgit Janssen; Ronald Bottlender; Anke Wieneke; Frauke Schulze-Lutter; Wolfgang Maier; Joachim Klosterkötter
Journal:  Br J Psychiatry Suppl       Date:  2005-08

5.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

6.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

7.  Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome.

Authors:  Scott W Woods; Alan Breier; Robert B Zipursky; Diana O Perkins; Jean Addington; Tandy J Miller; Keith A Hawkins; Eva Marquez; Stacy R Lindborg; Mauricio Tohen; Thomas H McGlashan
Journal:  Biol Psychiatry       Date:  2003-08-15       Impact factor: 13.382

Review 8.  Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

Authors:  Patrick D McGorry; Barnaby Nelson; G Paul Amminger; Andreas Bechdolf; Shona M Francey; Gregor Berger; Anita Riecher-Rössler; Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Merete Nordentoft; Ian Hickie; Philip McGuire; Michael Berk; Eric Y H Chen; Matcheri S Keshavan; Alison R Yung
Journal:  J Clin Psychiatry       Date:  2009-06-30       Impact factor: 4.384

9.  Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.

Authors:  Lisa J Phillips; Barnaby Nelson; Hok Pan Yuen; Shona M Francey; Magenta Simmons; Carrie Stanford; Margaret Ross; Daniel Kelly; Kathryn Baker; Philippe Conus; Paul Amminger; Francois Trumpler; Yang Yun; Michelle Lim; Catharine McNab; Alison R Yung; Patrick D McGorry
Journal:  Aust N Z J Psychiatry       Date:  2009-09       Impact factor: 5.744

10.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona Francey; Elizabeth M Cosgrave; Dominic Germano; Jenny Bravin; Tony McDonald; Alison Blair; Stephen Adlard; Henry Jackson
Journal:  Arch Gen Psychiatry       Date:  2002-10
View more
  10 in total

Review 1.  Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis.

Authors:  Paolo Fusar-Poli
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  Is symptomatic treatment an option for a boy with clinically significant psychotic-like experiences and depressed mood? Comment on Ruhrmann et al., "intervention in at-risk states for developing psychosis." (Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90-94).

Authors:  Hsiang-Yuan Lin; Yen-Nan Chiu; Chen-Chung Liu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-23       Impact factor: 5.270

Review 3.  Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome.

Authors:  Scott Richard Clark; Klaus Oliver Schubert; Bernhard Theodor Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-10-16       Impact factor: 3.575

4.  [Early recognition and intervention for bipolar disorders: state of research and perspectives].

Authors:  A Pfennig; C U Correll; K Leopold; G Juckel; M Bauer
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

5.  Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia.

Authors:  Andrea Raballo; Anna Meneghelli; Angelo Cocchi; Davide Sisti; Marco B L Rocchi; Andrea Alpi; Maria T Cascio; Antonio Preti; Kurt Maurer; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

6.  Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies.

Authors:  Paolo Fusar-Poli; Joaquim Radua; Philip McGuire; Stefan Borgwardt
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 7.  At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk.

Authors:  Paolo Fusar-Poli; Andreas Bechdolf; Matthew John Taylor; Ilaria Bonoldi; William T Carpenter; Alison Ruth Yung; Philip McGuire
Journal:  Schizophr Bull       Date:  2012-05-15       Impact factor: 9.306

8.  Emerging psychosis and the family.

Authors:  Martin Hambrecht
Journal:  ISRN Psychiatry       Date:  2012-04-23

Review 9.  Update on the development of lurasidone as a treatment for patients with acute schizophrenia.

Authors:  Norio Yasui-Furukori
Journal:  Drug Des Devel Ther       Date:  2012-05-08       Impact factor: 4.162

Review 10.  Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review.

Authors:  Cristiana Montemagni; Silvio Bellino; Nadja Bracale; Paola Bozzatello; Paola Rocca
Journal:  Front Psychiatry       Date:  2020-03-24       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.